Close

Syros Pharmaceuticals IPO Info

Company Name: Syros Pharmaceuticals
Stock Symbol: SYRS
Exchange: NASDAQ
Status: Priced
IPO Date: 6/30/2016
IPO Price: 12.50 (-2.72%)
Underwriters
Cowen and Company and Piper Jaffray & Co

Amount of Offering: N/A
Number of Shares Offered: 4 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes. Syros has built a proprietary platform that is designed to systematically and efficiently analyze this unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations.

News Headlines